Acute and Chronic Oral Magnesium Supplementation: Effects on Endothelial Function, Exercise Capacity, and Quality of Life in Patients With Symptomatic Heart Failure
Authors:
Open Access
- 29 January 2006
- journal article
- research article
- Published by Wiley in Congestive Heart Failure
- Vol. 12 (1) , 9-13
Abstract
Endothelial dysfunction is an important pathophysiologic mechanism in the progression of heart failure. The objective of the present study was to determine the effects of acute and chronic oral magnesium supplementation on endothelial function in patients with symptomatic heart failure. Twenty‐two symptomatic chronic heart failure patients were randomized to receive 800 mg oral magnesium oxide daily or placebo for 3 months. Data collected included large and small arterial elasticity/compliance, hemodynamic parameters, exercise capacity, and quality‐of‐life score at baseline, 1 week, and 3 months. Patients who received magnesium had improved small arterial compliance at 3 months from baseline compared with placebo. This study suggests that chronic supplementation with oral magnesium is well tolerated and could improve endothelial function in symptomatic heart failure patients.Keywords
This publication has 35 references indexed in Scilit:
- Noninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic EventsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Significance of magnesium in congestive heart failureAmerican Heart Journal, 1996
- Noninvasive Pulse Wave Analysis for the Early Detection of Vascular DiseaseHypertension, 1995
- Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)The Lancet, 1994
- The epidemiology of heart failure: The Framingham StudyJACC, 1993
- Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)The Lancet, 1992
- Hemodynamic effects of magnesium sulfate on the normal human heartThe American Journal of Cardiology, 1991
- One‐year death rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placeboClinical Cardiology, 1988
- Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortalityInternational Journal of Cardiology, 1986
- Effect of Magnesium Sulfate On Cardiovascular HemodynamicsAngiology, 1977